About

Publications While At HealthPartners

selected publications

Journal Article

Adjuvant platinum versus capecitabine for residual, invasive, triple-negative breast cancer: patient-reported outcomes in ECOG-ACRIN EA1131. 

Cancer. 2024

Randomized phase III postoperative trial of platinum-based chemotherapy versus capecitabine in patients with residual triple-negative breast cancer following neoadjuvant chemotherapy: ECOG-ACRIN EA1131. 

Journal of Clinical Oncology. 2021

Contact

full name

B. H. Park

Quick Info

 

Collaboration

Co-author network

Map of science